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mance. Clarify the ER estrogen stimulation of prostate cancer will be as
before this laboratory study in renal cancer cells by inhibiting AKT
pathway to inhibit tumor role.
Results: We found prostate cancer growth was inhibited by certain level of
Estrogen. The survival of prostate cancer was reduced up to 30%. Besides,
migration and invasion of prostate cancer cell were also inhibited by Es-
trogen. Estrogen also stimulate VEGFR signal of prostate cancer cell.
Conclusion: Estrogen has direct inhibitory effect on prostate cancer cell
growth. Further studies to identify the mechanism of Estrogen, androgen
receptor, RAS, EGFR pathway are needed.
NDP012:
EVALUATION OF FLUORODEOXYGLUCOSE POSITRON EMISSION
TOMOGRAPHY/COMPUTED TOMOGRAPHY FOR DIAGNOSIS AND
STAGING OF UPPER URINARY TRACT UROTHELIAL CARCINOMA
Kuan-Hsun Huang, Chien-Hui Ou, Wen-Horng Yang. Department of
Urology, Medical College and Hospital, National Cheng-Kung University,
Tainan, Taiwan
Purpose: To evaluate the ability of Fluorodeoxyglucose positron emission
tomography /computed tomography (18F-FDG PET-CT) in primary diag-
nosis and detection of upper urinary tract urothelial carcinoma by
comparing with ﬁnal pathological result.
Materials and Methods: We retrospectively evaluated clinicopathological
records of patients in our institute. All patients suspicious to have upper
urinary tracts malignancies were received 18F-FDG PET-CT, which was
followed by pathological-proved procedures such as ureteroscopic biopsy,
CT-guide biopsy, Nephroureterectomy or Hand-assisted Retroperitoneo-
scopic Nephroureterectomy (HARN). 21 patients were included in this
study. There were 12 women and 9 men with a median age of 76 years old
(range 34~89y/o).
Results: Of 21 patients in study group, 12 patients received HARN, 3 had
URS biopsy, 1 CT-guide biopsy and 5 open Nephroureterectomy. There
were 5, 3, 5, 7 patients with pTa, pT1, pT2, pT3 respectively. 3 patients were
diagnosed with lymph nodes metastasis by PET-CT, and 2 patients with
tissue proved lymph node metastasis. 20 showed deﬁnite FDG uptake in
initial or delay phase. Positive predictive rate was 95 %.
Conclusion: These preliminary results of this study with small number of
patients showed that FDG-PET/CT is another effective diagnosis in detec-
tion of UTUC.
NDP013:
THE PROGNOSTIC IMPACT OF MULTIFOCALITY FOR UPPER TRACT
UROTHELIAL CARCINOMA PATIENTS AFTER RADICAL
NEPHROURETERECTOMY
Ta-Yao Tai, Chien-Hui Ou. Department of Urology, National Cheng Kung
University Hospital, Tainan, Taiwan
Purpose: To evaluate the association between tumor multifocality of up-
per urinary tract urothelial carcinoma (UTUC) patients underwent radical
nephroureterectomy and validate the impact on oncologic outcomes in
those patients.
Materials and Methods: Patients who underwent nephroureterectomy
between November 2003 and November 2013 were identiﬁed from Na-
tional Cheng Kung University Hospital (NCKUH). Outcomes were ob-
tained via retrospective analysis of notes and electronic records. Overall
survival (OS), bladder recurrence-free survival (BRFS) were estimated
using KaplaneMeier methods and grade-stratiﬁed differences were
analyzed using the log-rank test. Tumor multifocality of UTUC was
deﬁned as the synchronous presence of multiple tumors in the renal
pelvis or ureter.
Results: Between November 2003 and November 2013, 269 patients un-
derwent nephroureterectomy of UTUC with a median age at diagnosis of
68 years. Median (range; mean) follow-up was 29 (2e120; 35.3) months.
In total, 34.5% (n¼ 69) of the patients had multifocal disease. The esti-
mated OS in multifocal tumor group and single tumor group were 58.8%
and 77.6%, respectively, at 5 years, and 44.1% and 59.7%, respectively, at 10
years (p¼ 0.0225). The estimated mean BRFS in multifocal tumor patientsand single tumor patients was 50.7% and 79.5%, respectively at 2 years and
47.8% and 74.5%, respectively, at 5 years (p<0.0001).
Conclusion: In this present single center cohort study, tumor multifocality
is an independent prognostic indicator of overall survival and bladder
recurrence-free survival in patients with UTUC treated with nephrour-
eterectomy.
NDP014:
CLINICAL FEATURES OF PATIENTS WITH NON-MALIGNANT UPPER
TRACT LESIONS MIMICKING UROTHELIAL CANCER
Ze-Hong Lu, Chien-Hui Ou. Department of Urology, National Cheng Kung
University Hospital, College of Medicine, National Cheng Kung University,
Tainan, Taiwan
Purpose: The aim of this retrospective study was to evaluate the incidence
and clinical features of patients undergone nephroureterectomy with non-
malignant upper tract lesions presumed to be urothelial carcinoma. The
clinicopathologic characteristics of these lesions were also determined.
Material and methods: Between Oct 2004 and Oct 2015, 350 patients
underwent retroperitoneoscopic nephroureterectomy for possible upper
urinary tract urothelial carcinoma without routinely ureteroscopic biopsy
of lesions at our institute. Twenty-three (6.6%) had non-malignant benign
lesions at the ﬁnal pathologic examination. The preoperative features of
these patients were investigated, including imaging ﬁndings, urine cyto-
logic results, and renal function status and previous history.
Results: The 23 patients comprised 9 men and 14 women. Initial symp-
toms included gross hematuria, hydronephrosis or repeated pyelone-
phritis. Urine cytologywere also collected for evaluation.We also reviewed
available abdomen computed tomography and retrograde pyelogram.
Three patients underwent preoperative ureteroscopy. 11 patients
(including 2 patient was post kidney transplantation status) had non-
functional kidney. We divided patient into two groups by renal function
status. The most common pathologic feature of ESRD group is atrophic
kidney. In the other hand, the most common diagnosis of the other group
of non-ERSD is pyelonephritis.
Conclusion: Non-malignant pathologic lesions were detected in twenty-
three (6.6%) patients who had undergone retroperitoneoscopic neph-
roureterectomy without preoperative ureteroscopic biopsies of uppertract
lesions.
NDP015:
CLINICAL AND THERAPEUTIC IMPLICATIONS OF NEUROENDOCRINE
PROSTATE CANCER: A LONG WINDING ROAD TO CURE
Chia-Lung Tsai, Kevin Lu, Hua-Pin Wang, Victor Chia-Hsiang Lin,
Tsan-Jung Yu. Division of Urology, Department of Surgery, E-Da Hospital,
School of Medicine, I-Shou University, Kaohsiung city, Taiwan
Purpose: Primary neuroendocrine cancer of prostate is an extremely rare
variant of prostate cancer, comprising 0.5% to 2% of prostate malignancies.
This entity encompasses various clinical contexts, ranging from the de
novo small cell carcinoma (SCC) to a treatment-emergent transformed
phenotype that arising from typical adenocarcinoma (Ad) of the prostate.
The rarity of these neoplasms poses a diagnostic and therapeutic chal-
lenge. Little is known about neuroendocrine prostate cancer and the cur-
rent knowledge of this disease is based on case reports or small series. Our
purpose was to characterize the cases treated at a tertiary academic center
and to evaluate patient outcomes with the available treatment modalities.
Materials and Methods: This was a single-institute retrospective obser-
vational cohort study of patients with neuroendocrine prostate cancer
followed at E-Da Hospital, Kaohsiung city, Taiwan between January 1, 2008
and October 1, 2013. Patient and tumor data were analyzed using
descriptive statistical methods.
Results: Among 826 prostate cancers, six patients were identiﬁed with
primary neuroendocrine prostate cancer, comprising 3 from de novo
mixed variety (SCC and Ad) and 3 from transformed phenotype (pure SCC).
The median age at diagnosis was 73.5 years. The most common presenting
symptoms were obstructive symptoms (weak stream, incomplete empty
and urine retention). The morphological appearance of the tumor cells and
their immunohistochemical reactivity for neuroendocrine markers, and
Abstracts / Urological Science 27 (2016) S53eS83 S57prostate speciﬁc antigen (PSA) helped establish the diagnosis. Overall
median survival was 12months from diagnosis of neuroendocrine prostate
cancer/prostate small cell carcinoma.
Conclusion: Primary neuroendocrine prostate cancer is characterized by
an aggressive clinical course with relatively short lifespan. Although high
response rate to cytotoxic chemotherapy, overall prognosis is poor. As
there is no standard of care for patients with neuroendocrine prostate
cancer, further efforts should be directed at its early detection and made to
develop more effective therapeutic strategy.
NDP016:
PRIMARY FEMALE URETHRAL ADENOCARCINOMA e REPORT OF 6
CASES AND REVIEW OF LITERATURE
Wei-Jen Chen 1, Tzu-Chun Wei 1,2, Junne-Yih Kuo 1,2, William J.S. Huang 1,2,
Alex T.L. Lin 1,2, Kuang-Kuo Chen 1,2. 1Department of Urology, Taipei
Veterans General Hospital, Taiwan; 2Department of Urology, School of
Medicine, and Shu-Tien Urological Institute, National Yang Ming University,
Taipei, Taiwan
Purpose: Female urethral carcinoma is rare and accounts for about 0.02%
of all female cancers and less than 1% of cancers in the female genitouri-
nary tract. It occurredmainly at proximal urethra and often presented with
adjacent organ invasion and metastatic disease at diagnosis, resulting in
poor prognosis. Literature was limited, with only 19 patients enrolled in
the largest case series. We presented our treatment options and the
outcome of female urethra adenocarcinoma in our hospital together with
literature review.
Materials and Methods: From 2004 to 2016, six female patients with
diagnosis of primary urethral adenocarcinoma in our hospital. The clinical
data, treatment option, pathological feature and outcomes were retro-
spectively reviewed.
Results: The mean agewas 63.3 years old (52e76). Five patients presented
with difﬁcult voiding initially, and the other one patient presented with
post voiding urine dribbling while her adenocarcinoma was diagnosed
within the urethral diverticulum. Two patients were diagnosed with local
disease (group 1); the other 4 patients (group 2) were diagnosed with
adjacent organ invasion (n¼ 2) or initial metastatic disease (n¼ 2). In
group 2 patients, all received transurethral resection of tumor, and adju-
vant chemotherapy. Two patients received further radiotherapy due to
locally advanced disease (tumors conﬁned in pelvis). For the 2 patients
with initial metastatic disease out of pelvis, despite surgery and systemic
chemotherapy, they were mortal 14 and 19 months after diagnosis. The 2
patients with initial locally advanced disease, who received transurethral
resection of tumor, concurrent chemo-radiotherapy, survived 8 and 9 years
respectively till now with disease under control. For the 2 patients with
initial local disease, one patient received urethrectomy with suprapubic
cystostomy for pT2 disease and has been followed without tumor recur-
rence for 4 years; the other one received wide tumor en bloc excision for
pT1 disease, and has been followed for 6 months also without tumor
recurrence.
Conclusion: Female urethral adenocarcinoma is an aggressive tumor, and
the survival is poor if initial metastatic disease was diagnosed. For local
disease or locally advanced disease which can be resected by anterior
exenteration, surgical intervention is suggested according to our experi-
ence and other series, with or without chemotherapy or radiotherapy. For
metastatic disease, whether chemotherapy or radiotherapy is beneﬁcial is
still controversial in literature due to rarity, however, in our series,
aggressive tumor treatment by chemotherapy and radiotherapy seemed to
be effective in patients with locally advanced disease conﬁned within the
pelvis.
NDP017:
EASILY OVERLOOKED URETER TUMOR e TWO CASES OF MOVABLE
URETER TUMORS MISTAKEN FOR BLADDER LESIONS IN INITIAL IMAGES
Chin-Heng Lu 1, Tzu-Ping Lin 1,2,3, Hsiao-Jen Chung 1,2,3, Alex Tong-Long
Lin 1,2,3, Kuang-Kuo Chen 1,2,3. 1Department of Urology, Taipei Veterans
General Hospital, Taipei, Taiwan; 2Department of Urology, School of
Medicine, National Yang-Ming University, Taiwan; 3 Shu-Tien Urological
Science Research Center, National Yang-Ming University, TaiwanPurpose: Primary ureteral neoplasms account for less than 1% of all
genitourinary neoplasms in adults. Benign ureteral masses represent up to
20% of ureteral neoplasms and the mesodermal benign tumor such as
Ureteral Fibroepithelial polyp (UFP) is more common. Herein, we report
two cases of large benign ureteral tumor including UFP and inﬂammatory
polyp. Both cases presented as a vegetative bladder mass which originated
from the ureter andwas excised ureteroscopically. Though there have been
multiple reports of UFP, the features thattumor elongated into the bladder
cavity which mimicked bladder mass and resected ureteroscopically was
rare.
Materials and Methods:
Case 1: A 52-year-old female is a patient of sarcoidosis with enlarged
lymph nodes at right para-trachea, pre-carina and right hilum in chest CT.
Abdominal CT revealed the segmental edematous swelling of left lower
third ureter till vesicoureteral junction (UVJ) as well as an intraluminal
space occupying lesion. There was no associating symptoms and signs like
fever, fatigue, pain or hematuria.
Case 2: A 66-year-old man has a history of right multicystic renal cell
carcinoma, status post laparoscopic partial nephrectomy. Prostate sono-
gram at health exam showed polypoid lesion about 1 cm in diameter in the
bladder. CT revealed ﬁlling defect at right middle to lower third ureter. No
fever or severe hematuria was noted.
Both cases received operation and operation ﬁndings were similar. We
could not ﬁnd the tumor by cystoscope at ﬁrst. The bladder mucosa was
intact without papillary tumor but one of the ureter oriﬁce (UO) was
dilated. A polypoid neoplasm protruding from the ureteral oriﬁce.
The vermiform shape neoplasm ﬂoated back and force with the peristalsis
of the ureter. Then ureteroscopy was performed. The long stripe of ureteral
tumor stemed from lower 1/3 ureter was noted. The tumor was resected
from the stalk by holmium laser ablation and then DJ was inserted
smoothly.
In case 1, a left 6.1 x 0.3 x 0.1 cm greyish white soft polypoid ureteritis
was resected. In case 2, a 6 x 0.5 x 0.5 cm greyish white soft ﬁbroepi-
thelial polyp was resected. The pathology showed ﬁbrovascular stroma
with overlying benign urothelium in a ﬁngerlike or polypoid conﬁgu-
ration. Both of the patients experienced uneventful perioperative
course.
Results: UFPs are hamartomas derived from ureteral mesenchyme, while
most ureteral malignancies arise from transitional epithelium. There were
only 2 cases of UFP from January 2005 to February 2016. UFPs are thought
to be either congenital slow-growing lesions or lesions that develop as a
result of chronic urothelial irritants, such as calculi or infections. UFPs
rarely recur once they are treated. Other benign lesions of the ureter
include endometriomas, ﬁbromas, leiomyomas, neuroﬁbromas, heman-
giomas, and lymphangiomas. In these two cases, the ureter tumors might
be neglected by routine sonographic checkup.
Conclusion: The elongated ureteral tumor may be neglected by sonogra-
phy image survey. If sonography indicated the tumor was near UO or
cystoscopy showed UO dilatation, URS laser ablation is effective in treating
such lesion.
NDP018:
PRIMARY ADENOCARCINOMA OF THE SEMINAL VESICLES e CASE
REPORT
Po-Chao Tsai 1, Yi-Hisen Chen 2, Chung-Jing Wang 1, Chien-Hsing Chang 1.
1Department of Urology, St. Martin De Porres Hospital, Chiayi, Taiwan;
2Department of Pathology, St. Martin De Porres Hospital, Chiayi, Taiwan
Purpose: We present a case of very rare malignant neoplasm derived from
the gland of the seminal vesicles.
Case presentation: The case involves a 53-year-old man who has dia-
betes mellitus under poor control before hospitalization. He came to our
emergency department due to general weakness and poor appetite. He
denied diarrhea, constipation, or dysuria. The physical examination
revealed chronically-ill appearance and clear consciousness. There was
no icteric sclera, no knocking tenderness of the ﬂank area, and no
tenderness of the abdomen. The digital rectal examination showed a
palpable rectal mass about 8cm above anal verge. Urinalysis showed
numerous red blood cells and white blood cells under high-powered-
ﬁelds. The serum survey revealed high C-reactive protein (18.24 mg/dL),
